Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease.

Alzheimer's disease (AD) is a neurodegenerative disease with broad impact. Although Aβ and tau have been proposed as the key molecules in the disease mechanism, comprehensive understanding of AD pathogenesis requires a systemic view at the genomic level. From studies on the brain transcriptome of AD, we have gradually realized the contribution of the immune system to AD development. Recent explorations on the blood transcriptome of AD patients have revealed robust immune activation in the peripheral blood. The combination of transcriptome studies and other types of studies has further elucidated the roles of specific immune pathways in distinct cell types during AD development and highlighted the critical contributions from immune genes such as TREM2.

[1]  A. Cuello,et al.  Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease , 2014, Neurobiology of Aging.

[2]  Ahmet Kurdoglu,et al.  Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes , 2015, Neurobiology of Aging.

[3]  Colin K. Combs,et al.  A Pilot Study to Assess Effects of Long-Term Inhalation of Airborne Particulate Matter on Early Alzheimer-Like Changes in the Mouse Brain , 2015, PloS one.

[4]  M. Liu,et al.  Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice , 2014, Neuroscience.

[5]  D. Choi,et al.  Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer’s disease mice model , 2013, Journal of Neuroinflammation.

[6]  M. Lynch,et al.  Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP/PS1 mice , 2014, Neurobiology of Aging.

[7]  C. Kruse,et al.  Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. , 2010, Brain : a journal of neurology.

[8]  J. Schug,et al.  RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment , 2015, Neurobiology of Disease.

[9]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[10]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Dominique Drouin,et al.  Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression , 2010, Alzheimer's & Dementia.

[12]  Fuhai Song,et al.  Common Aging Signature in the Peripheral Blood of Vascular Dementia and Alzheimer’s Disease , 2015, Molecular Neurobiology.

[13]  E. Hol,et al.  Reactive glia show increased immunoproteasome activity in Alzheimer's disease. , 2013, Brain : a journal of neurology.

[14]  Sara Reardon,et al.  Antibody drugs for Alzheimer’s show glimmers of promise , 2015, Nature.

[15]  J. Gallacher,et al.  Convergent genetic and expression data implicate immunity in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[16]  O. Korvatska,et al.  R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study. , 2015, JAMA neurology.

[17]  B. Nordestgaard,et al.  Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease , 2015, Alzheimer's & Dementia.

[18]  A. Palmeri,et al.  Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease. , 2015, Brain : a journal of neurology.

[19]  Magda Tsolaki,et al.  A blood gene expression marker of early Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[20]  M. Guillot-Sestier,et al.  Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology , 2015, Neuron.

[21]  A. Arefin,et al.  ‘Neuroinflammation’ differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared , 2014, neurogenetics.

[22]  J. Molinuevo,et al.  TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.

[23]  Dong-Hou Kim,et al.  Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome , 2014, Autophagy.

[24]  Carl W. Cotman,et al.  Gene expression changes in the course of normal brain aging are sexually dimorphic , 2008, Proceedings of the National Academy of Sciences.

[25]  O. Boutaud,et al.  Suppression of Alzheimer-Associated Inflammation by Microglial Prostaglandin-E2 EP4 Receptor Signaling , 2014, The Journal of Neuroscience.

[26]  L. Tan,et al.  Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice , 2014, Neurobiology of Aging.

[27]  E. Hol,et al.  Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction , 2014, Neurobiology of Aging.

[28]  Hongxing Lei,et al.  Down-regulation of energy metabolism in Alzheimer's disease is a protective response of neurons to the microenvironment. , 2012, Journal of Alzheimer's disease : JAD.

[29]  O. Garaschuk,et al.  Impairment of in vivo calcium signaling in amyloid plaque-associated microglia , 2014, Acta Neuropathologica.

[30]  Manolis Kellis,et al.  Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.

[31]  Fuhai Song,et al.  AlzBase: an Integrative Database for Gene Dysregulation in Alzheimer’s Disease , 2014, Molecular Neurobiology.

[32]  Sandeep Grover,et al.  Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease , 2014, BMC Genomics.

[33]  B. Finsen,et al.  Accelerated microglial pathology is associated with Aβ plaques in mouse models of Alzheimer’s disease , 2014, Aging cell.

[34]  Jennifer M. Pocock,et al.  Insights into TREM2 biology by network analysis of human brain gene expression data , 2013, Neurobiology of Aging.

[35]  A. Goate,et al.  Coding variants in TREM2 increase risk for Alzheimer's disease. , 2014, Human molecular genetics.

[36]  Guangchun Han,et al.  Robust gene dysregulation in Alzheimer's disease brains. , 2014, Journal of Alzheimer's disease : JAD.

[37]  G. Taglialatela,et al.  NFκB-Activated Astroglial Release of Complement C3 Compromises Neuronal Morphology and Function Associated with Alzheimer’s Disease , 2015, Neuron.

[38]  Corey O. Brizzee,et al.  BAG3 facilitates the clearance of endogenous tau in primary neurons , 2015, Neurobiology of Aging.

[39]  Daphne Koller,et al.  Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.

[40]  T. Montine,et al.  APOE genotype‐dependent modulation of astrocyte chemokine CCL3 production , 2015, Glia.

[41]  D. Aarsland,et al.  A novel blood test for the early detection of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[42]  D. Stephan,et al.  Genetic control of human brain transcript expression in Alzheimer disease. , 2009, American journal of human genetics.

[43]  R. Ransohoff,et al.  TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models , 2015, The Journal of experimental medicine.

[44]  T. Montine,et al.  Different mechanisms of apolipoprotein E isoform‐dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  Stefano Ruggieri,et al.  A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects , 2013, Journal of Neuroinflammation.

[46]  Hongxing Lei,et al.  Characteristic transformation of blood transcriptome in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[47]  G. Eslick,et al.  BACTERIAL INFECTION AND ALZHEIMER'S DISEASE: A META-ANALYSIS , 2014, Alzheimer's & Dementia.

[48]  D. Praticò,et al.  Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in a mouse model of Alzheimer's disease. , 2014, Human molecular genetics.

[49]  D. Mann,et al.  TREM2 analysis and increased risk of Alzheimer's disease , 2015, Neurobiology of Aging.

[50]  Lars Lannfelt,et al.  Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study. , 2013, Journal of Alzheimer's disease : JAD.

[51]  B. Loriod,et al.  Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease , 2014, Molecular Neurodegeneration.

[52]  Eric M Reiman,et al.  Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. , 2008, Physiological genomics.

[53]  Jiajia Wang,et al.  Genomics in Neurological Disorders , 2014, Genom. Proteom. Bioinform..

[54]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[55]  Guangchun Han,et al.  Distinctive RNA Expression Profiles in Blood Associated With Alzheimer Disease After Accounting for White Matter Hyperintensities , 2014, Alzheimer disease and associated disorders.

[56]  M. Leon,et al.  Periodontal disease associates with higher brain amyloid load in normal elderly , 2015, Neurobiology of Aging.

[57]  T. Möller,et al.  Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease , 2016, Glia.